chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: little redness and soreness at the injection arm; little redness and soreness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (little redness and soreness at the injection arm) and VACCINATION SITE PAIN (little redness and soreness at the injection arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (little redness and soreness at the injection arm) and VACCINATION SITE PAIN (little redness and soreness at the injection arm). At the time of the report, VACCINATION SITE ERYTHEMA (little redness and soreness at the injection arm) and VACCINATION SITE PAIN (little redness and soreness at the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Myalgia, Pain in extremity
Clinical narrative: pain in his bones; pain in the palm of his hands and feet; pain in his whole body; pain not only in his joints, but also in his bones; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (pain in his bones), PAIN IN EXTREMITY (pain in the palm of his hands and feet), MYALGIA (pain in his whole body) and ARTHRALGIA (pain not only in his joints, but also in his bones) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced BONE PAIN (pain in his bones), PAIN IN EXTREMITY (pain in the palm of his hands and feet), MYALGIA (pain in his whole body) and ARTHRALGIA (pain not only in his joints, but also in his bones). The patient was treated with CELECOXIB (CELEBREX) at an unspecified dose and frequency. At the time of the report, BONE PAIN (pain in his bones), PAIN IN EXTREMITY (pain in the palm of his hands and feet), MYALGIA (pain in his whole body) and ARTHRALGIA (pain not only in his joints, but also in his bones) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medicine.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Was diagnosed with COVID-19 two days after first dose of the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Was diagnosed with COVID-19 two days after first dose of the vaccine.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Was diagnosed with COVID-19 two days after first dose of the vaccine.). The patient was treated with PREDNISONE for COVID-19, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (Was diagnosed with COVID-19 two days after first dose of the vaccine.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, SARS-CoV-2 test: positive (abnormal) positve.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient also used V pack as treatment.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: Little bruises; Broke out in hives; Little red lumps in his hands, feet, legs and arms; Itching everywhere; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of URTICARIA (Broke out in hives), PERIPHERAL SWELLING (Little red lumps in his hands, feet, legs and arms), PRURITUS (Itching everywhere) and CONTUSION (Little bruises) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Exercise induced asthma (Caller is currently under no medical treatment.). Concurrent medical conditions included Drug allergy (allergic to ibuprofen).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced URTICARIA (Broke out in hives), PERIPHERAL SWELLING (Little red lumps in his hands, feet, legs and arms) and PRURITUS (Itching everywhere). On 02-Feb-2021, the patient experienced CONTUSION (Little bruises). The patient was treated with PREDNISONE (oral) at an unspecified dose and frequency. At the time of the report, URTICARIA (Broke out in hives) and PRURITUS (Itching everywhere) had resolved and PERIPHERAL SWELLING (Little red lumps in his hands, feet, legs and arms) and CONTUSION (Little bruises) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: a red patch around my arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (a red patch around my arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (a red patch around my arm). At the time of the report, ERYTHEMA (a red patch around my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not reported. No Treatment information was provided. Patient reports that "this could also be a burn from hot water"   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: CROSSLINK CASE MOD21-018137
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: difficulty in moving L arm; itchy, light red patch at the injection site; light red patch on injection site; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (difficulty in moving L arm), VACCINATION SITE PRURITUS (itchy, light red patch at the injection site), VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE ERYTHEMA (light red patch on injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042I20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Septra), Drug allergy (Amoxicillin) and Drug allergy (Advil/Motrin/Ibuprofen).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore at the injection site). On 31-Jan-2021, the patient experienced LIMB DISCOMFORT (difficulty in moving L arm), VACCINATION SITE PRURITUS (itchy, light red patch at the injection site) and VACCINATION SITE ERYTHEMA (light red patch on injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 23-Jan-2021, VACCINATION SITE PAIN (sore at the injection site) had resolved. At the time of the report, LIMB DISCOMFORT (difficulty in moving L arm), VACCINATION SITE PRURITUS (itchy, light red patch at the injection site) and VACCINATION SITE ERYTHEMA (light red patch on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Skin burning sensation
Clinical narrative: burning skin rash on feet and legs for the last 3 days; A spontaneous report was received from a Consumer concerning a 77-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events skin burning sensation.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 032H20A) in left arm for prophylaxis of COVID-19 infection.  On an unknown date the patient experienced skin burning sensation.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, skin burning sensation was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced RASH (Rash on arm). At the time of the report, RASH (Rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Headache, Myalgia
Clinical narrative: Tested COVID19 positive; Loss of taste; Loss of smell; Headaches; Fever; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested COVID19 positive), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), HEADACHE (Headaches) and PYREXIA (Fever) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 29-Jan-2021, the patient experienced COVID-19 (Tested COVID19 positive), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), HEADACHE (Headaches), PYREXIA (Fever) and MYALGIA (Body Aches). At the time of the report, COVID-19 (Tested COVID19 positive), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), HEADACHE (Headaches), PYREXIA (Fever) and MYALGIA (Body Aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, SARS-CoV-2 test: unknown (Positive) COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Patient stated that she is completely fine now but she is under quarantine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Tested COVID19 positive; Loss of taste; Loss of smell; Headaches; Fever; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested COVID19 positive), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), HEADACHE (Headaches) and PYREXIA (Fever) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 29-Jan-2021, the patient experienced COVID-19 (Tested COVID19 positive), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), HEADACHE (Headaches), PYREXIA (Fever) and MYALGIA (Body Aches). At the time of the report, COVID-19 (Tested COVID19 positive), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), HEADACHE (Headaches), PYREXIA (Fever) and MYALGIA (Body Aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, SARS-CoV-2 test: unknown (Positive) COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Patient stated that she is completely fine now but she is under quarantine.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Feeling abnormal, Feeling hot, Gait disturbance
Clinical narrative: Aches, Pains; Couldn't walk well; Hot; Swollen; Red; Brain fog; Couldn't lay on arm, couldn't touch arm, arm felt like it was broken; Vomiting; Shaky; Ran temperature of 99 degrees; nausea; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen) and ERYTHEMA (Red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 30-Dec-2020. Concomitant products included PARACETAMOL (TYLENOL), CEFTRIAXONE SODIUM (ROCEPHIN), SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen), ERYTHEMA (Red), FEELING ABNORMAL (Brain fog), PAIN IN EXTREMITY (Couldn't lay on arm, couldn't touch arm, arm felt like it was broken), VOMITING (Vomiting), CHILLS (Shaky), PYREXIA (Ran temperature of 99 degrees) and NAUSEA (nausea). At the time of the report, PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen), ERYTHEMA (Red), FEELING ABNORMAL (Brain fog), PAIN IN EXTREMITY (Couldn't lay on arm, couldn't touch arm, arm felt like it was broken), VOMITING (Vomiting), CHILLS (Shaky), PYREXIA (Ran temperature of 99 degrees) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, SARS-CoV-2 antibody test: positive (Positive) Positive. On 21-Jan-2021, Pyrexia: 99 (High) 99 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was not hospitalized but was recommended to by healthcare professional. Treatment information include Tylenol, Rocephin, Dactrim.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pain in extremity, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: Aches, Pains; Couldn't walk well; Hot; Swollen; Red; Brain fog; Couldn't lay on arm, couldn't touch arm, arm felt like it was broken; Vomiting; Shaky; Ran temperature of 99 degrees; nausea; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen) and ERYTHEMA (Red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 30-Dec-2020. Concomitant products included PARACETAMOL (TYLENOL), CEFTRIAXONE SODIUM (ROCEPHIN), SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen), ERYTHEMA (Red), FEELING ABNORMAL (Brain fog), PAIN IN EXTREMITY (Couldn't lay on arm, couldn't touch arm, arm felt like it was broken), VOMITING (Vomiting), CHILLS (Shaky), PYREXIA (Ran temperature of 99 degrees) and NAUSEA (nausea). At the time of the report, PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen), ERYTHEMA (Red), FEELING ABNORMAL (Brain fog), PAIN IN EXTREMITY (Couldn't lay on arm, couldn't touch arm, arm felt like it was broken), VOMITING (Vomiting), CHILLS (Shaky), PYREXIA (Ran temperature of 99 degrees) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, SARS-CoV-2 antibody test: positive (Positive) Positive. On 21-Jan-2021, Pyrexia: 99 (High) 99 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was not hospitalized but was recommended to by healthcare professional. Treatment information include Tylenol, Rocephin, Dactrim.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vomiting
Clinical narrative: Aches, Pains; Couldn't walk well; Hot; Swollen; Red; Brain fog; Couldn't lay on arm, couldn't touch arm, arm felt like it was broken; Vomiting; Shaky; Ran temperature of 99 degrees; nausea; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen) and ERYTHEMA (Red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 30-Dec-2020. Concomitant products included PARACETAMOL (TYLENOL), CEFTRIAXONE SODIUM (ROCEPHIN), SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) and SEMAGLUTIDE (OZEMPIC) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen), ERYTHEMA (Red), FEELING ABNORMAL (Brain fog), PAIN IN EXTREMITY (Couldn't lay on arm, couldn't touch arm, arm felt like it was broken), VOMITING (Vomiting), CHILLS (Shaky), PYREXIA (Ran temperature of 99 degrees) and NAUSEA (nausea). At the time of the report, PAIN (Aches, Pains), GAIT DISTURBANCE (Couldn't walk well), FEELING HOT (Hot), SWELLING (Swollen), ERYTHEMA (Red), FEELING ABNORMAL (Brain fog), PAIN IN EXTREMITY (Couldn't lay on arm, couldn't touch arm, arm felt like it was broken), VOMITING (Vomiting), CHILLS (Shaky), PYREXIA (Ran temperature of 99 degrees) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, SARS-CoV-2 antibody test: positive (Positive) Positive. On 21-Jan-2021, Pyrexia: 99 (High) 99 degree Celsius.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was not hospitalized but was recommended to by healthcare professional. Treatment information include Tylenol, Rocephin, Dactrim.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Heart rate increased, Myalgia
Clinical narrative: she usually have 85-87 BPM heartrate it went up to over 100 that day; shortness of breath; injection site was terribly itchy; Injection site was hard; injection site was red; rash under the injection site; Chills; muscle ache; severe nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (she usually have 85-87 BPM heartrate it went up to over 100 that day), DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (injection site was terribly itchy), VACCINATION SITE INDURATION (Injection site was hard) and VACCINATION SITE ERYTHEMA (injection site was red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CHONDROITIN SULFATE SODIUM, GLUCOSAMINE (GLUCOSAMINE AND CHONDROITIN), MAGNESIUM, ESTRADIOL, CLONAZEPAM, BUPROPION HYDROCHLORIDE (WELLBUTRIN), ALENDRONATE SODIUM (ALENDRONATE) and VILAZODONE HYDROCHLORIDE (VIIBRYD) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced HEART RATE INCREASED (she usually have 85-87 BPM heartrate it went up to over 100 that day), DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (injection site was terribly itchy), VACCINATION SITE INDURATION (Injection site was hard), VACCINATION SITE ERYTHEMA (injection site was red), VACCINATION SITE RASH (rash under the injection site), CHILLS (Chills), MYALGIA (muscle ache), NAUSEA (severe nausea) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 29-Jan-2021, HEART RATE INCREASED (she usually have 85-87 BPM heartrate it went up to over 100 that day), DYSPNOEA (shortness of breath), CHILLS (Chills), MYALGIA (muscle ache), NAUSEA (severe nausea) and HEADACHE (Headache) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site was terribly itchy), VACCINATION SITE INDURATION (Injection site was hard), VACCINATION SITE ERYTHEMA (injection site was red) and VACCINATION SITE RASH (rash under the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Non-significant TCR FU -  Adress provided; Reporter's Comments: .
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site rash
Clinical narrative: she usually have 85-87 BPM heartrate it went up to over 100 that day; shortness of breath; injection site was terribly itchy; Injection site was hard; injection site was red; rash under the injection site; Chills; muscle ache; severe nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (she usually have 85-87 BPM heartrate it went up to over 100 that day), DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (injection site was terribly itchy), VACCINATION SITE INDURATION (Injection site was hard) and VACCINATION SITE ERYTHEMA (injection site was red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CHONDROITIN SULFATE SODIUM, GLUCOSAMINE (GLUCOSAMINE AND CHONDROITIN), MAGNESIUM, ESTRADIOL, CLONAZEPAM, BUPROPION HYDROCHLORIDE (WELLBUTRIN), ALENDRONATE SODIUM (ALENDRONATE) and VILAZODONE HYDROCHLORIDE (VIIBRYD) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced HEART RATE INCREASED (she usually have 85-87 BPM heartrate it went up to over 100 that day), DYSPNOEA (shortness of breath), VACCINATION SITE PRURITUS (injection site was terribly itchy), VACCINATION SITE INDURATION (Injection site was hard), VACCINATION SITE ERYTHEMA (injection site was red), VACCINATION SITE RASH (rash under the injection site), CHILLS (Chills), MYALGIA (muscle ache), NAUSEA (severe nausea) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 29-Jan-2021, HEART RATE INCREASED (she usually have 85-87 BPM heartrate it went up to over 100 that day), DYSPNOEA (shortness of breath), CHILLS (Chills), MYALGIA (muscle ache), NAUSEA (severe nausea) and HEADACHE (Headache) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site was terribly itchy), VACCINATION SITE INDURATION (Injection site was hard), VACCINATION SITE ERYTHEMA (injection site was red) and VACCINATION SITE RASH (rash under the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Non-significant TCR FU -  Adress provided; Reporter's Comments: .
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: some areas are red; rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso) and ERYTHEMA (some areas are red) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Medication for high blood pressure for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced RASH (rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso). On 30-Jan-2021, the patient experienced ERYTHEMA (some areas are red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 30-Jan-2021 to 01-Feb-2021 at an unspecified dose and frequency. At the time of the report, RASH (rash under the breast/ it got worse and expanded to the side of neck / it got worse and expanded to the side of torso) and ERYTHEMA (some areas are red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported "On Saturday 30Jan2021 it got worse and expanded to the side of neck and side of torso" Patient reported "the rash under the breast is now gone"
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Loss of personal independence in daily activities, Nausea, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to email/fax form back), DIZZINESS (lightheaded and constant dizzinesss), VACCINATION SITE PAIN (soreness of the injection arm) and NAUSEA (a little nauseated) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. Concurrent medical conditions included Glaucoma and Blood pressure. Concomitant products included MESALAZINE (MESALAMINE) for Ulcerative colitis, MULTIVITAMINS [VITAMINS NOS] and HYDROCHLOROTHIAZIDE for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness of the injection arm). On 03-Feb-2021, the patient experienced DIZZINESS (lightheaded and constant dizzinesss) and NAUSEA (a little nauseated). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to email/fax form back). At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Unable to email/fax form back), DIZZINESS (lightheaded and constant dizzinesss), VACCINATION SITE PAIN (soreness of the injection arm) and NAUSEA (a little nauseated) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications reported were Blood Pressure medicine, Eye drops for glaucoma, Allergy medicine and Medicine for his prostate. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow up received on 10-June-21. No new information provided. According to the information  provided by the CC agent and confirmed by caller there is no previous case corresponding to provided names, telephone number or address. On 13-Jul-2021: Follow up received on 13 JUL 2021 and added concomitant medication. added newevent.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall
Clinical narrative: Fell; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FALL (Fell) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (Unspecified surgery done 5 years ago.). Concurrent medical conditions included Coronary artery disease.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DIZZINESS (Dizziness). On 27-Jan-2021, the patient experienced FALL (Fell). At the time of the report, DIZZINESS (Dizziness) and FALL (Fell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate, Heart rate increased, Hypertension, Pain in extremity
Clinical narrative: High blood pressure; High pulse; felt like something was not right; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of   in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Cholesterol total abnormal NOS. Concomitant products included LISINOPRIL, ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) and EFINACONAZOLE (JUBLIA) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with LISINOPRIL at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, Heart rate: over 100 (High) over 100. On 24-Jan-2021, Hypertension: over 200 (High) over 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itchiness at injection site; Redness at injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at injection site), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (Redness at injection site) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O3222OA) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GLYBURIDE and LISINOPRIL for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchiness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient treated with Benadryl; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: SORE ARM; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (SORE ARM) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (SORE ARM). On 08-Jan-2021, VACCINATION SITE PAIN (SORE ARM) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Right arm pit got swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Right arm pit got swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (Right arm pit got swollen). At the time of the report, SWELLING (Right arm pit got swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Great deal of redness and swelling at the site; Great deal of redness and swelling at the site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Great deal of redness and swelling at the site) and VACCINATION SITE SWELLING (Great deal of redness and swelling at the site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Great deal of redness and swelling at the site) and VACCINATION SITE SWELLING (Great deal of redness and swelling at the site). At the time of the report, VACCINATION SITE ERYTHEMA (Great deal of redness and swelling at the site) and VACCINATION SITE SWELLING (Great deal of redness and swelling at the site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (My arm, where the vaccine was, is red), VACCINATION SITE SWELLING (My arm, where the vaccine was, is swollen) and VACCINATION SITE PRURITUS (My arm, where the vaccine was, is itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (My arm, where the vaccine was, is red), VACCINATION SITE SWELLING (My arm, where the vaccine was, is swollen) and VACCINATION SITE PRURITUS (My arm, where the vaccine was, is itchy). At the time of the report, VACCINATION SITE ERYTHEMA (My arm, where the vaccine was, is red), VACCINATION SITE SWELLING (My arm, where the vaccine was, is swollen) and VACCINATION SITE PRURITUS (My arm, where the vaccine was, is itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No relevant concomitant medications were reported. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Inappropriate schedule of product administration, Pyrexia, Rash
Clinical narrative: It looks like I got bad sun burn, its peeling; Inappropriate schedule of vaccine administered; Bad rash in the right leg going from knee to ankle/burny; Rash was red; Rash was itchy; Bad chills; Fever; I could not get warm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (I could not get warm), RASH ERYTHEMATOUS (Rash was red), RASH PRURITIC (Rash was itchy), CHILLS (Bad chills) and PYREXIA (Fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced FEELING COLD (I could not get warm), CHILLS (Bad chills) and PYREXIA (Fever). On 06-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Rash was red), RASH PRURITIC (Rash was itchy) and RASH (Bad rash in the right leg going from knee to ankle/burny). On 28-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 01-Feb-2021, the patient experienced SUNBURN (It looks like I got bad sun burn, its peeling). The patient was treated with ZYRTEC [CETIRIZINE HYDROCHLORIDE] at an unspecified dose and frequency. On 05-Jan-2021, FEELING COLD (I could not get warm), CHILLS (Bad chills) and PYREXIA (Fever) had resolved. At the time of the report, RASH ERYTHEMATOUS (Rash was red), RASH PRURITIC (Rash was itchy), RASH (Bad rash in the right leg going from knee to ankle/burny), SUNBURN (It looks like I got bad sun burn, its peeling) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.            Concomitant medications reported were unspecified cholesterol pill 20mg for unknown indication. Treatment details included "Anti itch cream to stop the rash on my leg"   This case was linked to MOD-2021-195245 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Sunburn
Clinical narrative: It looks like I got bad sun burn, its peeling; Inappropriate schedule of vaccine administered; Bad rash in the right leg going from knee to ankle/burny; Rash was red; Rash was itchy; Bad chills; Fever; I could not get warm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (I could not get warm), RASH ERYTHEMATOUS (Rash was red), RASH PRURITIC (Rash was itchy), CHILLS (Bad chills) and PYREXIA (Fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced FEELING COLD (I could not get warm), CHILLS (Bad chills) and PYREXIA (Fever). On 06-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Rash was red), RASH PRURITIC (Rash was itchy) and RASH (Bad rash in the right leg going from knee to ankle/burny). On 28-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 01-Feb-2021, the patient experienced SUNBURN (It looks like I got bad sun burn, its peeling). The patient was treated with ZYRTEC [CETIRIZINE HYDROCHLORIDE] at an unspecified dose and frequency. On 05-Jan-2021, FEELING COLD (I could not get warm), CHILLS (Bad chills) and PYREXIA (Fever) had resolved. At the time of the report, RASH ERYTHEMATOUS (Rash was red), RASH PRURITIC (Rash was itchy), RASH (Bad rash in the right leg going from knee to ankle/burny), SUNBURN (It looks like I got bad sun burn, its peeling) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.            Concomitant medications reported were unspecified cholesterol pill 20mg for unknown indication. Treatment details included "Anti itch cream to stop the rash on my leg"   This case was linked to MOD-2021-195245 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash macular
Clinical narrative: Three days ago arm got more sore and there was a red spot that has now expanded to entire arm; arm soreness initially; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness initially) and RASH MACULAR (Three days ago arm got more sore and there was a red spot that has now expanded to entire arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness initially). On 29-Jan-2021, the patient experienced RASH MACULAR (Three days ago arm got more sore and there was a red spot that has now expanded to entire arm). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of 3 times total; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; CEFALEXIN (KEFLEX [CEFALEXIN]) at a dose of 3.5 g for 18 hours and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness initially) and RASH MACULAR (Three days ago arm got more sore and there was a red spot that has now expanded to entire arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient also reports taking 3.5g of Keflex for 18 hours then discontinued after learning about "COVID arm". Taken 3 doses of bactrim due to fears of cellulitis and MRSA.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Bruise; Rash at the injection site; Injection site quite red; Injection site sore; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), VACCINATION SITE PRURITUS (Rash at the injection site), VACCINATION SITE ERYTHEMA (Injection site quite red) and VACCINATION SITE PAIN (Injection site sore) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse event). Concomitant products included CHLORPHENIRAMINE MALEATE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Rash at the injection site), VACCINATION SITE ERYTHEMA (Injection site quite red) and VACCINATION SITE PAIN (Injection site sore). On 31-Jan-2021, the patient experienced CONTUSION (Bruise). On 31-Jan-2021, VACCINATION SITE PRURITUS (Rash at the injection site), VACCINATION SITE ERYTHEMA (Injection site quite red) and VACCINATION SITE PAIN (Injection site sore) had resolved. At the time of the report, CONTUSION (Bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: Body ache; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.